BALYASNY ASSET MANAGEMENT L.P. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2022. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$25,000
-51.9%
22,443
+19.6%
0.00%
Q4 2021$52,00018,7630.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,750,107$10,875,0000.41%
Plante Moran Financial Advisors, LLC 50,000$145,0000.05%
Donald L. Hagan, LLC 14,000$40,0000.04%
Game Plan Financial Advisors, LLC 11,000$32,0000.03%
Tekla Capital Management LLC 165,330$479,0000.02%
Virtu Financial LLC 52,655$153,0000.02%
SIGNATUREFD, LLC 58,326$169,0000.01%
OXFORD ASSET MANAGEMENT LLP 131,783$382,0000.01%
Lindbrook Capital, LLC 10,000$29,0000.01%
WEDBUSH SECURITIES INC 40,700$118,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders